Applications to the Fiscal Year 2023 (FY23) Bone Marrow Failure Research Program (BMFRP)
are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using
delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001). The
execution management agent for this program announcement is the Congressionally Directed
Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development
Command (USAMRDC). The BMFRP was initiated in FY08 to provide support for research of
exceptional scientific merit. Appropriations for the BMFRP from FY08 through FY22 totaled
$56.55 million (M). The FY23 appropriation is $7.5M.
The vision of the BMFRP is to understand and cure bone marrow failure (BMF) diseases.
Toward that end, the program challenges the scientific community to design innovative research
approaches based on sound scientific evidence that will advance the understanding and treatment
of inherited and acquired BMF diseases to improve the health of affected Service Members,
Veterans, and the general public, with the ultimate goals of prevention and cure
Deadline: Pre-Application (Preproposal): June 21, 2023 5:00 p.m. Eastern Time (ET)